A Prospective, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Trial of Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Ulinastatin (Primary)
- Indications Sepsis; Septic shock
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 11 Dec 2016 Planned End Date changed from 1 Apr 2018 to 1 Aug 2018.
- 11 Dec 2016 Planned primary completion date changed from 1 Jan 2018 to 1 May 2018.